Menu
Not yet recruiting NCT07702929

Effect of Hand Rehabilitation on Cognitive Function in Patients With PD

No phase Interventional PARKINSON DISEASE (Disorder)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Hand Sensorimotor Rehabilitation, Cognitive Remediation.
Who it may be relevant to
Registry conditions: PARKINSON DISEASE (Disorder). Basic parameters: 45 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of Sensory-motor Rehabilitation of the Hand on Cognitive Functions in Patients With Parkinson's Disease

Overview

Evidence suggests the association between fine motor skills of the hand and cognitive function, as well as the positive effects of hand rehabilitation on hand function and the effectiveness of cognitive rehabilitation on cognitive functions in patients with Parkinson's disease (PD). In response to the question of whether there is a cause-and-effect relationship between fine manual skills and cognitive function, we designed the present randomized controlled trial to investigate the effectiveness of sensory-motor rehabilitation of the hand on cognitive functions compared to the effectiveness of cognitive rehabilitation on sensory-motor skills of the hand in patients with PD. In this double-blinded, randomized controlled trial, a convenience sample including 48 people with PD will participate based on simple non-random sampling. The participants will be allocated randomly through stratified randomization to parallel groups of intervention (sensorimotor hand rehabilitation) and control (cognitive rehabilitation) with a 1:1 allocation ratio. The associate researcher responsible for assessing outcome measures and the statistician responsible for analyzing the data are blinded to the intervention protocol. The intervention protocol for the intervention group includes hand sensory-motor rehabilitation for 10 one-and-a-half-hour sessions, 3 sessions per week, in addition to cognitive rehabilitation for 10 one-and-a-half-hour sessions, 3 sessions per week. The intervention protocol for the control group includes cognitive rehabilitation for 10 one-and-a-half-hour sessions, 3 sessions per week. All participants undergo three assessment sessions: the day before the intervention, the day after the intervention, and one month after the last intervention session. Data will be analyzed using SPSS version 22.0. The significance level will be set at 0.05.

Interventions

  • Other Hand Sensorimotor Rehabilitation
    10 one-and-a-half-hour sessions, 3 sessions per week
  • Other Cognitive Remediation
    10 one-and-a-half-hour sessions, 3 sessions per week

Primary outcome measures

  • Montreal Cognitive Assessment [Time frame: - The day before the intervention - The day after the intervention - One month after the last intervention session]
  • Cambridge Neuropsychological Test Automated Battery - Reaction Time [Time frame: - The day before the intervention - The day after the intervention - One month after the last intervention session]
  • Cambridge Neuropsychological Test Automated Battery - Spatial Span Test [Time frame: - The day before the intervention - The day after the intervention - One month after ending intervention]
  • Cambridge Neuropsychological Test Automated Battery - Match to Sample Visual Search Test [Time frame: - The day before the intervention - The day after the intervention - One month after the last intervention session]
  • Cambridge Neuropsychological Test Automated Battery - Stop Signal Task [Time frame: - The day before the intervention - The day after the intervention - One month after the last intervention session]
  • KING'S PD Pain Scale [Time frame: - The day before staring intervention - The day after ending intervention - one month after ending intervention]
  • Box & Block Test [Time frame: - The day before starting intervention - The day after ending intervention - One month after ending intervention]
  • The Purdue Pegboard Test [Time frame: - The day before starting intervention - The day after ending intervention - One month after ending intervention]
  • Hand Dynamometer Hydraulic Jamar [Time frame: - The day before starting intervention - The day after ending intervention - One month after ending intervention]
  • Pinch gauge [Time frame: - The day before starting intervention - The day after ending intervention - One month after ending intervention]

Eligibility criteria

Inclusion criteria

  • A diagnosis of PD by a neurologist based on the Movement Disorders Society Clinical Diagnostic Criteria for Parkinson's Disease;
  • 45-65 years old: age of peak incidence of PD;
  • Minimum 2 years and maximum 10 years from initial diagnosis: stabilization of the disease process and medications;
  • disability level of at most 3 in the Modified Hoehn and Yahr Scale: physically independent;
  • Mild cognitive impairment: score between 20 and 26 in Montreal cognitive assessment;
  • Signing the written informed consent.

Exclusion criteria

  • Patients with neurological diseases other than PD
  • Patients with orthopedic and internal diseases that would make participation in the study difficult

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07702929 · 2404210

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗